Results in 1-6 Months*
Free, Fast & Discrete Delivery
GMC Registered Doctors
From
£149.00
£109.00
/ month
Get a personalised treatment plan, approved by licensed providers — and have Mounjaro delivered discreetly to your door. Safe. Fast. Effective.
Get a personalised treatment plan, approved by licensed providers — and have Mounjaro delivered discreetly to your door. Safe. Fast. Effective.
Effectiveness
Average 15% Weight Loss*
Format
Easy Injection
Results
In 1-6 Months
Online Approval Time
Less than 5 Minutes
Achieve your goals with transparent, affordable pricing for our medically supervised weight loss injections.
Starts From
£149.00
£109.00
/ month
Here's what to expect from our science-based service.
Complete a quick, secure medical questionnaire — it only takes a few minutes. Your answers will help our licensed providers understand your health profile and weight loss goals.
A board-certified provider reviews your submission. If approved, they’ll prescribe Mounjaro and create a custom plan tailored to you. We’re here to answer any questions along the way.
Your prescription is shipped discreetly to your door through a licensed UK pharmacy. Start your journey with ongoing support and guidance from our care team.
Effective solutions for weight loss backed by our clinical team.
Clinically-proven weight loss
From £149.00 £109.00 / month
Start your online consultation today. If you're eligible, you'll quickly receive your clinically prescribed medication.
Lose weight and transform the way you think about food. Boost your fitness, energy levels, and confidence along the way.
With ongoing support, build sustainable lifestyle habits that help you maintain your weight loss long term.
We’ll review your lifestyle, medical history, weight, and current medications during our online consultation. This helps our clinicians choose the most appropriate treatment for you. The process only takes a few minutes to complete.
Gastrointestinal symptoms—such as nausea, diarrhea, stomach pain, and constipation—are the most common side effects of GLP-1 medications. These typically ease as your body adapts. For a comprehensive list of all potential side effects, including rarer ones, please refer to the Patient Information Leaflet.
Individual results will vary, but healthy weight loss happens gradually. Maintaining that loss can be one of the greatest challenges, which is why WeightlossRx's programme integrates behaviour change. It targets essential areas—nutrition, exercise, and mindset—to support lasting success.
Programme pricing varies by medication and dose strength, with higher-strength pens priced above lower ones. Monthly costs (before any discounts) are:
Wegovy
Mounjaro
The WeightlossRx Programme blends weight loss medication with continuous clinical support and expert guidance. By tackling all the key factors of weight management, it equips you with the tools to achieve lasting, sustainable results.
Our Weight Loss Programme supports individuals with overweight or obesity in reaching a healthier weight. Our clinicians perform personalised assessments, reviewing each case individually to ensure the programme is right for you.
We’re committed to the highest standards of quality and safety in all aspects of our care. Every medication we prescribe is rigorously researched and grounded in solid evidence. Semaglutide, in particular, is approved for long-term obesity treatment and has been shown in clinical trials to lower the risk of serious cardiovascular events, such as heart attack and stroke.
Our clinicians will collaborate with you to determine the ideal duration for your prescribed medication, tailoring their recommendation to your unique needs and circumstances.
Mounjaro (tirzepatide): Based on tirzepatide once weekly for 72 weeks in the SURMOUNT-1 trial. Jastreboff AM, Aronne LJ, Ahmad NN, Wharton S, Connery L, Alves B, Kiyosue A, Zhang S, Liu B, Bunck MC, Stefanski A & the SURMOUNT-1 Investigators. Tirzepatide once weekly for the treatment of obesity. The New England Journal of Medicine. 2022.*
Wegovy (semaglutide): Based on semaglutide once weekly for 68 weeks in the STEP 1 trial. Wilding JPH, Rubino D, Davies MJ, et al. Once-weekly semaglutide in adults with overweight or obesity. The New England Journal of Medicine. 2021. Results measured in participants who adhered to the dosing schedule and reached the maximum dose of semaglutide.*